• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

Ultrahuman hires chief business officer as it scales expansion for glucose monitoring tech

October 18, 2021 By Sean Whooley

Ultrahuman Cyborg
[Image from Ultrahuman]
Metabolic tracking technology developer Ultrahuman announced today that it appointed Bhuvan Srinivasan as its first chief chief business officer.

The appointment of Srinivasan to the new role follows Bangalore, India-based Ultrahuman’s $17.5 million Series B financing round completed in August.

Ultrahuman develops the Ultrahuman Cyborg, a continuous metabolism tracker designed to help people with diabetes track blood glucose in real-time and optimize their diet and exercise. The company says its platform goes beyond traditional markers like body mass index, weight and point-in-time blood tests, utilizing biomarkers to tell users how their body reacts to a certain type of food, how to fuel efficiently for exercise and how to eat for better sleep.

Bhuvan’s experience prior to joining Ultrahuman includes more than 14 years in consultancy and private equity. He most recently served as a director in KKR’s India team, leading investments in pharma, hospitals, waste management, tech and education, according to a news release.

“We are navigating our scale-up journey and having people like Bhuvan will certainly bolster our efforts,” Ultrahuman founder & CEO Mohit Kumar said in the release. His appointment is part of the next phase of growth and his experience in building businesses will provide the perspective and guidance Ultrahuman requires as we charter the course.”

He also held positions with Bain Capital and Bain & Company. He began his career as a research scientist working on continuous glucose monitoring with Medtronic’s diabetes arm in Los Angeles.

“Life has come full circle for me in joining Ultrahuman. I began my career as a research scientist for glucose sensors for diabetes. Since then, I have benefitted from working closely with a range of businesses and people, skills that I will be able to utilize in driving the future trajectory of Ultrahuman as it scales globally,” added Srinivasan. “Research over the last 15 years has shown that good glucose control is important for preventing other diseases as well, including cardiovascular disease, Alzheimer’s and even cancer. I have been an avid supporter of the business over the years and am thrilled to be joining this amazing group of people who are focussed on making a huge impact.”

Filed Under: Business/Financial News, Diabetes, Featured, Patient Monitoring, Technology Tagged With: Personnel, Personnel Moves, Ultrahuman

IN CASE YOU MISSED IT

  • Dexcom CFO to expand into COO role
  • Beta Bionics insulin patch pump scores FDA clearance
  • Medtronic moves to divest final stake in MiniMed
  • Dexcom adds former Stryker CFO to board
  • MiniMed wins CE mark for next-gen insulin pump, ups revenue guidance

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS